MX2010005453A - Preparacion que contiene bacteria de acido lactico. - Google Patents
Preparacion que contiene bacteria de acido lactico.Info
- Publication number
- MX2010005453A MX2010005453A MX2010005453A MX2010005453A MX2010005453A MX 2010005453 A MX2010005453 A MX 2010005453A MX 2010005453 A MX2010005453 A MX 2010005453A MX 2010005453 A MX2010005453 A MX 2010005453A MX 2010005453 A MX2010005453 A MX 2010005453A
- Authority
- MX
- Mexico
- Prior art keywords
- lactic acid
- acid bacterium
- function
- containing preparation
- nite
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 10
- 241000894006 Bacteria Species 0.000 title abstract 5
- 235000014655 lactic acid Nutrition 0.000 title abstract 5
- 239000004310 lactic acid Substances 0.000 title abstract 5
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 abstract 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
Se proporciona una composición útil que contiene una bacteria productora de ácido láctico altamente segura o un componente que se origina en esta bacteria de ácido láctico. Específicamente, una composición que contiene al menos una bacteria de ácido láctico seleccionada del grupo que consiste de Lactobacillus delbrueckii subespecie lactis KR-037 cepa (NITE BP-395), Lactobacillus delbrueckii subespecie lactis KLAB-4 cepa (NITE BP-394) y variantes de las mismas o un componente que se origina en la bacteria de ácido láctico. La composición anteriormente descrita es útil como una preparación que tiene una excelente función anti-alérgica, junto con al menos una función seleccionada de entre una función contra las enfermedades auto-inmunitarias, una función del mejoramiento de la diabetes, una función de disminución de las grasas neutras.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007299503 | 2007-11-19 | ||
| PCT/JP2008/070995 WO2009066681A1 (ja) | 2007-11-19 | 2008-11-19 | 乳酸菌含有製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010005453A true MX2010005453A (es) | 2010-08-31 |
Family
ID=40667503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005453A MX2010005453A (es) | 2007-11-19 | 2008-11-19 | Preparacion que contiene bacteria de acido lactico. |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20100278795A1 (es) |
| EP (1) | EP2223697B1 (es) |
| JP (1) | JP5554994B2 (es) |
| MX (1) | MX2010005453A (es) |
| WO (1) | WO2009066681A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5945092B2 (ja) * | 2010-08-11 | 2016-07-05 | サッポロホールディングス株式会社 | 中性脂肪低減剤 |
| JP2012056921A (ja) * | 2010-09-13 | 2012-03-22 | Kaneka Corp | 生菌製剤 |
| JP6777911B2 (ja) * | 2016-08-17 | 2020-10-28 | 株式会社明治 | 抗インフルエンザ薬による獲得免疫機能低下抑制用発酵乳およびその製造方法 |
| US9795579B1 (en) * | 2017-04-24 | 2017-10-24 | Knoze Jr. Corporation | Oral microbiota promoting method |
| KR102194286B1 (ko) * | 2018-02-08 | 2020-12-22 | 주식회사 엠디헬스케어 | 락토코커스 속 세균 유래 나노소포 및 이의 용도 |
| JP6747724B2 (ja) * | 2018-05-28 | 2020-08-26 | 株式会社ライフ・クオリティ研究所 | 低血糖改善剤及び低血糖改善用組成物 |
| US20230000933A1 (en) * | 2019-12-02 | 2023-01-05 | Life Quality Institute, Inc. | Agent for prevention or remediation of stress disorders and composition containing same |
| WO2021111983A1 (ja) * | 2019-12-02 | 2021-06-10 | 株式会社ライフ・クオリティ研究所 | 機能性身体症候群の予防又は改善用剤及びそれを含む組成物 |
| EP4070806A1 (en) | 2019-12-02 | 2022-10-12 | Life Quality Institute, Inc. | Prophylactic or ameliorating agent for orthostatic hypotension, and composition containing same |
| JP7057039B2 (ja) * | 2019-12-02 | 2022-04-19 | 株式会社ライフ・クオリティ研究所 | 認知症の予防又は改善用剤及びそれを含む組成物 |
| JP7426820B2 (ja) * | 2019-12-27 | 2024-02-02 | 雪印メグミルク株式会社 | 食後血糖値上昇抑制用組成物及びその製造方法 |
| TWI776433B (zh) * | 2021-03-22 | 2022-09-01 | 生合生物科技股份有限公司 | 戴白氏乳桿菌乳酸亞種ldl557分離株及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH092959A (ja) * | 1995-06-16 | 1997-01-07 | Yakult Honsha Co Ltd | ＩｇＥ抗体産生抑制剤および抗アレルギー剤 |
| JPH107577A (ja) | 1996-06-17 | 1998-01-13 | Yakult Honsha Co Ltd | 血糖降下剤 |
| JPH10139674A (ja) * | 1996-11-11 | 1998-05-26 | Yakult Honsha Co Ltd | インターロイキン１２産生促進剤 |
| JPH10298083A (ja) | 1997-04-28 | 1998-11-10 | Wakamoto Pharmaceut Co Ltd | 高脂血症治療用組成物および高脂血症対応食品 |
| JP4580542B2 (ja) * | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
| US20040047849A1 (en) * | 2002-09-11 | 2004-03-11 | Genmont Biotech Inc. | Use of some lactobacillus strains in treating allergy |
| KR100908254B1 (ko) * | 2003-03-13 | 2009-07-20 | 기린 홀딩스 가부시키가이샤 | 항알레르기용 조성물 |
| JP2007082403A (ja) * | 2004-03-26 | 2007-04-05 | Nippon Medicine:Kk | ユッカ抽出物、キラヤ抽出物及び乳酸菌の複合組成物を含有する飲食品及びその製造法 |
| TW200637908A (en) * | 2005-01-04 | 2006-11-01 | Calpis Co Ltd | Method for preparation of lactic acid bacterium having anti-allergic activity |
| JP2007070249A (ja) * | 2005-09-05 | 2007-03-22 | Shinshu Univ | 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品 |
-
2008
- 2008-11-19 MX MX2010005453A patent/MX2010005453A/es active IP Right Grant
- 2008-11-19 EP EP08851191.0A patent/EP2223697B1/en active Active
- 2008-11-19 JP JP2009542564A patent/JP5554994B2/ja active Active
- 2008-11-19 WO PCT/JP2008/070995 patent/WO2009066681A1/ja active Application Filing
- 2008-11-19 US US12/743,485 patent/US20100278795A1/en not_active Abandoned
-
2015
- 2015-03-10 US US14/642,796 patent/US9737577B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2223697B1 (en) | 2016-04-06 |
| EP2223697A4 (en) | 2011-04-27 |
| US9737577B2 (en) | 2017-08-22 |
| US20100278795A1 (en) | 2010-11-04 |
| WO2009066681A1 (ja) | 2009-05-28 |
| EP2223697A1 (en) | 2010-09-01 |
| US20150182566A1 (en) | 2015-07-02 |
| JP5554994B2 (ja) | 2014-07-23 |
| JPWO2009066681A1 (ja) | 2011-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010005453A (es) | Preparacion que contiene bacteria de acido lactico. | |
| NZ598751A (en) | Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175)) | |
| WO2009112361A3 (en) | Synbiotic mixture | |
| SG10201901259RA (en) | Prebiotic formulations and methods of use | |
| MX2009012255A (es) | Probioticos en ambiente pre y/o postquirurgico. | |
| MX2008006546A (es) | Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria. | |
| IN2012DN01638A (es) | ||
| WO2009043856A3 (en) | Modulation of tissue fatty acid composition of a host by human gut bacteria | |
| WO2008053444A3 (en) | Treating a respiratory condition with bifidobacterium | |
| ZA200805413B (en) | Method for modifying gut flora in animals | |
| BR112013028705A2 (pt) | cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes | |
| WO2008117266A3 (en) | Probiotic bifidobacterium strains | |
| GB2460781A (en) | Probiotic bifidobacterium strains | |
| WO2011106322A3 (en) | Biomarkers for acute ischemic stroke | |
| MX2009008580A (es) | Composiciones lubricantes personales complementarias y sistema de administracion. | |
| TW200700074A (en) | Inducer of t cell apoptosis | |
| NZ603065A (en) | Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions | |
| UA94056C2 (uk) | Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій | |
| ZA201109086B (en) | Prevention and treatment of allergic diarrhoea | |
| PL1812023T3 (pl) | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające | |
| WO2011080396A3 (en) | Probiotic bifidobacterial composition in accordance with secretor blood group status | |
| WO2009019320A3 (en) | Method for inducing and accelerating cells | |
| WO2012039615A3 (en) | Commensal rat ileum bacterium (crib) | |
| MX2012013835A (es) | Cepas probioticas para aumentar la resistencia transepitelial. | |
| MX2008008157A (es) | Control de sindromes inflamatorios intestinales con una preparacion de bacterias exterminadas o no infecciosas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |